{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:43:04Z","timestamp":1794368584761,"version":"4.9.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is characterized by a low 5-year survival rate. Despite having many clinical metrics to assess patient prognosis, there remain opportunities to improve risk stratification. We hypothesized that an underexplored resource to examine the prognosis of patients with AML is plasma metabolome. Circulating metabolites are influenced by patients\u2019 clinical status and can serve as accessible cancer biomarkers. To establish a resource of circulating metabolites in genetically diverse patients with AML, we performed an unbiased metabolomic and lipidomic analysis of 231 diagnostic AML plasma samples before treatment with intensive chemotherapy. Intriguingly, circulating metabolites were highly associated with the mutation status within the AML cells. Furthermore, lipids were associated with refractory status. We established a machine learning algorithm trained on chemotherapy-refractory\u2013associated lipids to predict patient survival. Cox regression and Kaplan-Meier analysis demonstrated that the high-risk lipid signature predicted overall survival in this patient cohort. Impressively, the top lipid in the high-risk lipid signature, sphingomyelin (d44:1), was sufficient to predict overall survival in both the original data set and an independent validation data set. Overall, this research underscores the potential of circulating metabolites to capture AML heterogeneity and lipids to be used as potential AML biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025029132","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T20:04:03Z","timestamp":1756238643000},"page":"2589-2596","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-4918","authenticated-orcid":false,"given":"Cristiana","family":"O\u2019Brien","sequence":"first","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"},{"name":"2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-5863","authenticated-orcid":false,"given":"Nirvana","family":"Nursimulu","sequence":"additional","affiliation":[{"name":"2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9455-2591","authenticated-orcid":false,"given":"Anit","family":"Tyagi","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-083X","authenticated-orcid":false,"given":"Rachel","family":"Culp-Hill","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Arruda","sequence":"additional","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Murphy","sequence":"additional","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-8816","authenticated-orcid":false,"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"},{"name":"2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kent","sequence":"additional","affiliation":[{"name":"4Division of Hematology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Stevens","sequence":"additional","affiliation":[{"name":"4Division of Hematology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-4860","authenticated-orcid":false,"given":"Daniel A.","family":"Pollyea","sequence":"additional","affiliation":[{"name":"4Division of Hematology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Hope","sequence":"additional","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"},{"name":"2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Kumar","sequence":"additional","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"},{"name":"2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-4963","authenticated-orcid":false,"given":"Julie A.","family":"Reisz","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-6490","authenticated-orcid":false,"given":"Angelo","family":"D'Alessandro","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-1493","authenticated-orcid":false,"given":"Courtney L.","family":"Jones","sequence":"additional","affiliation":[{"name":"1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"},{"name":"5Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9","key":"2025112011213712500_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clml.2021.05.016","article-title":"Acute myeloid leukemia: historical perspective and progress in research and therapy over 5 decades","volume":"21","author":"Kantarjian","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"17","key":"2025112011213712500_bib2","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.3390\/cancers14174166","article-title":"A focus on intermediate-risk acute myeloid leukemia: sub-classification updates and therapeutic challenges","volume":"14","author":"Awada","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"2025112011213712500_bib3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.2016.148825","article-title":"An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation","volume":"101","author":"Ferguson","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"2025112011213712500_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"10393","key":"2025112011213712500_bib5","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"1","key":"2025112011213712500_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40364-024-00600-1","article-title":"Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark Res"},{"issue":"6","key":"2025112011213712500_bib7","doi-asserted-by":"crossref","first-page":"e0129260","DOI":"10.1371\/journal.pone.0129260","article-title":"Multi-organ contribution to the metabolic plasma profile using hierarchical modelling","volume":"10","author":"Torell","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"2025112011213712500_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3945\/ajcn.116.135301","article-title":"Comparing metabolite profiles of habitual diet in serum and urine","volume":"104","author":"Playdon","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"2025112011213712500_bib9","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112011213712500_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1741-7015-11-60","article-title":"Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"key":"2025112011213712500_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.envint.2018.11.034","article-title":"Impact of short-term traffic-related air pollution on the metabolome - Results from two metabolome-wide experimental studies","volume":"123","author":"van Veldhoven","year":"2019","journal-title":"Environ Int"},{"issue":"7","key":"2025112011213712500_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3109\/07420528.2012.699122","article-title":"Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach","volume":"29","author":"Ang","year":"2012","journal-title":"Chronobiol Int"},{"issue":"7836","key":"2025112011213712500_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41586-020-2896-2","article-title":"A reference map of potential determinants for the human serum metabolome","volume":"588","author":"Bar","year":"2020","journal-title":"Nature"},{"issue":"9","key":"2025112011213712500_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11306-016-1093-7","article-title":"Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics","volume":"12","author":"Armitage","year":"2016","journal-title":"Metabolomics"},{"issue":"1","key":"2025112011213712500_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40364-023-00507-3","article-title":"Cancer metabolites: promising biomarkers for cancer liquid biopsy","volume":"11","author":"Wang","year":"2023","journal-title":"Biomark Res"},{"issue":"10","key":"2025112011213712500_bib16","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/pr400403p","article-title":"Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis","volume":"12","author":"Wang","year":"2013","journal-title":"J Proteome Res"},{"key":"2025112011213712500_bib17","doi-asserted-by":"crossref","first-page":"30693","DOI":"10.1038\/srep30693","article-title":"Serum metabonomics of acute leukemia using nuclear magnetic resonance spectroscopy","volume":"6","author":"Musharraf","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"2025112011213712500_bib18","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41598-018-23863-9","article-title":"Distinct metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood acute myeloid leukemia","volume":"8","author":"Stockard","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"2025112011213712500_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12944-017-0624-1","article-title":"Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia","volume":"16","author":"W\u0105tek","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2025112011213712500_bib20","doi-asserted-by":"crossref","first-page":"21809","DOI":"10.1038\/s41598-023-48970-0","article-title":"Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy","volume":"13","author":"Bolkun","year":"2023","journal-title":"Sci Rep"},{"key":"2025112011213712500_bib21","doi-asserted-by":"crossref","first-page":"1235160","DOI":"10.3389\/fmolb.2023.1235160","article-title":"Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients","volume":"10","author":"Ar\u00e9valo","year":"2023","journal-title":"Front Mol Biosci"},{"key":"2025112011213712500_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-9236-2_8","article-title":"Untargeted and semi-targeted lipid analysis of biological samples using mass spectrometry-based metabolomics","volume":"1978","author":"Reisz","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2025112011213712500_bib23","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1038\/s41467-024-48009-6","article-title":"MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics","volume":"15","author":"Pang","year":"2024","journal-title":"Nat Commun"},{"key":"2025112011213712500_bib24","doi-asserted-by":"publisher","DOI":"10.1101\/274969","article-title":"LIPEA: lipid pathway enrichment analysis","author":"Acevedo","year":"3  2018","journal-title":"bioRxiv"},{"key":"2025112011213712500_bib25","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.28022.1","article-title":"BioPAN: a web-based tool to explore mammalian lipidome metabolic pathways on LIPID MAPS","volume":"10","author":"Gaud","year":"2021","journal-title":"F1000Res"},{"issue":"6","key":"2025112011213712500_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/biomedicines10061359","article-title":"2-Hydroxyglutarate in acute myeloid leukemia: a journey from pathogenesis to therapies","volume":"10","author":"Raimondi","year":"2022","journal-title":"Biomedicines"},{"issue":"43","key":"2025112011213712500_bib27","doi-asserted-by":"crossref","first-page":"E6669","DOI":"10.1073\/pnas.1603876113","article-title":"ATM\/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia","volume":"113","author":"Gregory","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112011213712500_bib28","article-title":"Unraveling lipid metabolism for acute myeloid leukemia therapy","author":"O'Brien","year":"2024","journal-title":"Curr Opin Hematol"},{"issue":"web server issue","key":"2025112011213712500_bib29","doi-asserted-by":"crossref","first-page":"W606","DOI":"10.1093\/nar\/gkm324","article-title":"LIPID MAPS online tools for lipid research","volume":"35","author":"Fahy","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2025112011213712500_bib30","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"7633","key":"2025112011213712500_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"issue":"24","key":"2025112011213712500_bib32","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.3390\/cancers15245866","article-title":"Acid ceramidase inhibitor LCL-805 antagonizes Akt signaling and promotes iron-dependent cell death in acute myeloid leukemia","volume":"15","author":"Ung","year":"2023","journal-title":"Cancers"},{"issue":"50","key":"2025112011213712500_bib33","doi-asserted-by":"crossref","first-page":"83208","DOI":"10.18632\/oncotarget.13079","article-title":"Acid ceramidase is upregulated in AML and represents a novel therapeutic target","volume":"7","author":"Tan","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"2025112011213712500_bib34","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41467-025-56520-7","article-title":"Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis","volume":"16","author":"Sun","year":"2025","journal-title":"Nat Commun"},{"issue":"S1","key":"2025112011213712500_bib35","doi-asserted-by":"crossref","first-page":"147.1","DOI":"10.1096\/fasebj.29.1_supplement.147.1","article-title":"Ceramide mediated lethal mitophagy: a novel cell death mechanism in FLT3 targeted therapy for acute myeloid leukemia","volume":"29","author":"Dany","year":"2015","journal-title":"FASEB J"},{"issue":"5","key":"2025112011213712500_bib36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/bloodadvances.2023010535","article-title":"Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes","volume":"8","author":"Paudel","year":"2024","journal-title":"Blood Adv"},{"key":"2025112011213712500_bib37","doi-asserted-by":"crossref","first-page":"1281141","DOI":"10.3389\/fmolb.2023.1281141","article-title":"A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia","volume":"10","author":"Wu","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2025112011213712500_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/genes15010063","article-title":"A comprehensive metabolism-related gene signature predicts the survival of patients with acute myeloid leukemia","volume":"15","author":"Zhai","year":"2023","journal-title":"Genes"},{"issue":"2","key":"2025112011213712500_bib39","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3390\/curroncol30020193","article-title":"A novel fatty acid metabolism-associated risk model for prognosis prediction in acute myeloid leukaemia","volume":"30","author":"Wang","year":"2023","journal-title":"Curr Oncol"},{"key":"2025112011213712500_bib40","doi-asserted-by":"crossref","first-page":"1290968","DOI":"10.3389\/fimmu.2023.1290968","article-title":"A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"2025112011213712500_bib41","doi-asserted-by":"crossref","first-page":"20322","DOI":"10.1038\/s41598-021-99586-1","article-title":"Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls","volume":"11","author":"Wolrab","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"2025112011213712500_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/pharmaceutics15020437","article-title":"Lipid biomarkers in liquid biopsies: novel opportunities for cancer diagnosis","volume":"15","author":"Sagini","year":"2023","journal-title":"Pharmaceutics"},{"key":"2025112011213712500_bib43","doi-asserted-by":"crossref","first-page":"950732","DOI":"10.3389\/fonc.2023.950732","article-title":"Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia","volume":"13","author":"Bai","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"2025112011213712500_bib44","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s10753-023-01924-0","article-title":"Evaluation of serum paraoxonase, myeloperoxidase, and HDL-cholesterol levels in acute myeloid leukemia","volume":"46","author":"Sincan","year":"2023","journal-title":"Inflammation"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/21\/2589\/2421292\/blood_bld-2025-029132-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/21\/2589\/2421292\/blood_bld-2025-029132-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:21:59Z","timestamp":1763655719000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/21\/2589\/546894\/Plasma-lipid-levels-predict-chemotherapy-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,11,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025029132","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,20]]},"published":{"date-parts":[[2025,11,20]]}}}